Segment disclosures

Company overview

경동제약

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 49 retained observations 33 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3052261526410 KRW20260814Open filing evidence
2026-01-01 – 2026-06-30100075952675 KRW20260814Open filing evidence
2026-01-01 – 2026-03-3147814426265 KRW20260514Open filing evidence
2025-01-01 – 2025-12-31196273042787 KRW20260320Open filing evidence
2025-07-01 – 2025-09-3048881462457 KRW20251114Open filing evidence
2025-01-01 – 2025-09-30144110530937 KRW20251114Open filing evidence
2025-04-01 – 2025-06-3049416502805 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3095229068480 KRW20260814Open filing evidence
2025-01-01 – 2025-03-3145812565675 KRW20260514Open filing evidence
2024-01-01 – 2024-12-31193936297352 KRW20260320Open filing evidence
2024-07-01 – 2024-09-3049633096155 KRW20251114Open filing evidence
2024-01-01 – 2024-09-30144408672176 KRW20251114Open filing evidence
2024-04-01 – 2024-06-3049690057493 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3094775576021 KRW20250814Open filing evidence
2024-01-01 – 2024-03-3145085518528 KRW20250514Open filing evidence
2023-01-01 – 2023-12-31162674098953 KRW20260320Open filing evidence
2023-07-01 – 2023-09-3039039208897 KRW20241113Open filing evidence
2023-01-01 – 2023-09-30117894970716 KRW20241113Open filing evidence
2023-04-01 – 2023-06-3041328143293 KRW20240814Open filing evidence
2023-01-01 – 2023-06-3078855761819 KRW20240814Open filing evidence
2023-01-01 – 2023-03-3137527618526 KRW20240514Open filing evidence
2022-01-01 – 2022-12-31182718157223 KRW20250320Open filing evidence
2022-07-01 – 2022-09-3047473091592 KRW20231114Open filing evidence
2022-01-01 – 2022-09-30134904194279 KRW20231114Open filing evidence
2022-04-01 – 2022-06-3040294203279 KRW20230814Open filing evidence
2022-01-01 – 2022-06-3087431102687 KRW20230814Open filing evidence
2022-01-01 – 2022-03-3147136899408 KRW20230515Open filing evidence
2021-01-01 – 2021-12-31177610830014 KRW20240321Open filing evidence
2021-07-01 – 2021-09-3049358132028 KRW20221114Open filing evidence
2021-01-01 – 2021-09-30130716942593 KRW20221114Open filing evidence
2021-04-01 – 2021-06-3042403961219 KRW20220816Open filing evidence
2021-01-01 – 2021-06-3081358810565 KRW20220816Open filing evidence
2021-01-01 – 2021-03-3138954849346 KRW20220516Open filing evidence
2020-01-01 – 2020-12-31173827660003 KRW20230322Open filing evidence
2020-07-01 – 2020-09-3045796199592 KRW20211115Open filing evidence
2020-01-01 – 2020-09-30128650575686 KRW20211115Open filing evidence
2020-04-01 – 2020-06-3041924769720 KRW20210813Open filing evidence
2020-01-01 – 2020-06-3082854376094 KRW20210813Open filing evidence
2020-01-01 – 2020-03-3140929606374 KRW20210517Open filing evidence
2019-01-01 – 2019-12-31176500194696 KRW20220321Open filing evidence
2019-07-01 – 2019-09-3044968189433 KRW20201116Open filing evidence
2019-01-01 – 2019-09-30130059573866 KRW20201116Open filing evidence
2019-04-01 – 2019-06-3044009991586 KRW20200814Open filing evidence
2019-01-01 – 2019-06-3085091384433 KRW20200814Open filing evidence
2019-01-01 – 2019-03-3141081392847 KRW20200515Open filing evidence
2018-01-01 – 2018-12-31179316262050 KRW20210319Open filing evidence
2018-07-01 – 2018-09-3046904177617 KRW20191114Open filing evidence
2018-01-01 – 2018-09-30133469839178 KRW20191114Open filing evidence
2017-01-01 – 2017-12-31177772468130 KRW20200327Open filing evidence